Publications by authors named "Anna Andreou"

Claim this Profile
A
A prospective real-world analysis of intravenous eptinezumab in migraine management: the first UK experience.
Anna P Andreou, Bethany Hill, Rand Al-Rawi, Madeleine Murphy, Isabel Soares

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Modulation of Brain Activity: A Narrative Review.
Aisha Zhantleuova, Altynay Karimova, Anna P Andreou, Almira M Kustubayeva, Rashid Giniatullin

Biomedicines· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ongoing pursuit of migraine triggering mechanisms.
Anna P Andreou, Luigi Francesco Iannone

Cephalalgia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects and predictors of intravenous lidocaine infusion for patients with fibromyalgia.
Min Liu, Stephany Harris, Anna P Andreou, Adnan Al-Kaisy, David Pang

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in clinical presentations and sensory profiles in patients with fibromyalgia: implications of peripheral and central mechanisms.
Min Liu, Stephany Harris, Anna P Andreou, Xuenong Bo, Adnan Al-Kaisy

Pain Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis.
Michail Vikelis, Dimitrios Rikos, Andreas A Argyriou, Emmanouil V Dermitzakis, Anna P Andreou

Expert Rev Neurother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry.
Andreas A Argyriou, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Dimitrios Rikos, Dimitrios Rallis, Anna P Andreou

Expert Rev Neurother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic Applications.
Aisha Zhantleuova, Charlotte Leese, Anna P Andreou, Altynay Karimova, Guy Carpenter

Toxins (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review.
Dimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, Panagiotis Soldatos, Dimitrios Rallis, Anna P Andreou

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine headache pathophysiology.
Anna P Andreou, Ana D Pereira

Handb Clin Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistant and refractory migraine: clinical presentation, pathophysiology, and management.
Raffaele Ornello, Anna P Andreou, Eleonora De Matteis, Tim P Jürgens, Mia T Minen

EBioMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis.
Giorgio Lambru, Valeria Caponnetto, Bethany Hill, Susanna Ratti, Simona Sacco, Anna P Andreou

Neurotherapeutics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5-HT receptor as the target of ditans in migraine - from bench to bedside.
Dimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, Bianca Raffaelli, Håkan Ashina, Anna Andreou

Nat Rev Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The increasing role of electronic media in headache.
Thien Phu Do, Anna P Andreou, Arao Belitardo de Oliveira, Robert E Shapiro, Christian Lampl

BMC Neurol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis.
Anna P Andreou, Matteo Fuccaro, Bethany Hill, Madeleine Murphy, Valeria Caponnetto

J Headache Pain· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCN2 Ion Channels Drive Pain in Rodent Models of Migraine.
Christoforos Tsantoulas, Aidan Ng, Larissa Pinto, Anna P Andreou, Peter A McNaughton

J Neurosci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors.
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Anna Andreou

Int J Environ Res Public Health· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Anna P Andreou

J Headache Pain· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients.
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Anna P Andreou

Pain Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine.
Giorgio Lambru, Silvia Benemei, Anna P Andreou, Michelangelo Luciani, Gianluca Serafini

Pain Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Anna P Andreou

Pain Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Neuromodulation in Headache: An Update.
Joseph Lloyd, Maryna Biloshytska, Anna P Andreou, Giorgio Lambru

Neurol India· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential actions of indomethacin: clinical relevance in headache.
Oliver Summ, Anna P Andreou, Simon Akerman, Philip R Holland, Jan Hoffmann

Pain· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine.
Anna P Andreou, Charlotte Leese, Rosaria Greco, Chiara Demartini, Eve Corrie

Neurotherapeutics· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden Caffeine Withdrawal Triggers Migraine-A Randomized Controlled Trial.
Karl B Alstadhaug, Hilde Karen Ofte, Kai Ivar Müller, Anna P Andreou

Front Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis